$36.86
-3.02-7.57%
At close: -
$36.71
-0.15-0.41%
After Hours: 7:05 PM EDT
Comments
Loading...
Bright Minds Biosciences (NASDAQ:DRUG) Stock, Earnings Estimates, EPS, And Revenue
Bright Minds Biosciences reports earnings on a quarterly basis. These quarterly earnings reports give investors a glimpse into financial results from a company for a 3 month period. Earnings reports almost always include EPS and Revenue results.
Earnings Date
Aug 14
EPS
$0.050
Quarterly Revenue
$0
Annual Revenue
(as of Jun 30)
(as of Jun 30)
–
Analyze the earnings history of Bright Minds Biosciences using advanced sorting and filters.
Data brought to you by Benzinga APIs
Bright Minds Biosciences (DRUG) Earnings Per Share
Quarterly Earnings Surprise Amount
| Fiscal Quarter End | Date Reported | Actual EPS | Estimated EPS | Surprise % |
|---|---|---|---|---|
Bright Minds Biosciences (DRUG) Revenue
Quarterly Revenue Surprise Amount
| Fiscal Quarter End | Date Reported | Actual Revenue | Estimated Revenue | Surprise % |
|---|---|---|---|---|
FAQ
When is Bright Minds Biosciences (NASDAQ:DRUG) reporting earnings?
Bright Minds Biosciences (DRUG) is scheduled to report earnings on February 11, 2025. The last reported earnings were for reported on August 14, 2024 for Q3.
What were the latest earnings per share (EPS) for Bright Minds Biosciences (NASDAQ:DRUG)?
The Actual EPS was $0.05, which beat the estimate of $0.00.
What were Bright Minds Biosciences’s (NASDAQ:DRUG) revenues?
The Actual Revenue was $0K, which hit the estimate of $0K.
Browse earnings estimates, EPS, and revenue on all stocks.